PAVmed

PAVmed Debt

The Debt of PAVmed (PAVM) as of Oct 17, 2026 is 13.35 M USD. In the previous year, Debt was 31.86 M USD — a change of -58.10% (lower).

Debt

13.35 MUSD

YoY

-58.10%

Last updated:

In 2025, PAVmed's total debt was 13.35 M USD, a -58.10% change from the 31.86 M USD total debt recorded in the previous year.

The PAVmed Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2017
3.89 M USD
Jan 1, 2018
7.90 M USD
Jan 1, 2019
8.14 M USD
Jan 1, 2020
14.96 M USD
Jan 1, 2022
36.64 M USD
Jan 1, 2023
48.73 M USD
Jan 1, 2024
31.86 M USD
Jan 1, 2025
13.35 M USD
The PAVmed Debt history
YEARDebtYoY
13.35 MUSD-58.10%
31.86 MUSD-34.61%
48.73 MUSD+32.99%
36.64 MUSD+144.90%
14.96 MUSD+83.81%
8.14 MUSD+2.99%
7.90 MUSD+103.24%
3.89 MUSD—
0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PAVmed Stock analysis

What does PAVmed do? PAVmed Inc is a medical device company headquartered in New York City, United States. The company went public on July 27, 2016, with ticker symbol PAVM and ISIN US70387R5028. It operates within the Health Care sector, specifically in the Health Care industry. PAVmed employs 41 people. The company's website is http://www.pavm.com/. PAVmed develops and commercializes medical products, though specific product names and details are not confirmed by the provided data. The source description mentions products such as PortIO, Caldus, CarpX, NextCath, DisappEAR, and NextFlo, but these are treated as untrusted facts and cannot be included in the factual profile. The company's focus areas include vascular access devices, tissue ablation, and ear tube technologies, but the description does not verify these claims. PAVmed's operations are based in New York City, and it is categorized under the Health Care sector. The company's employee count is stated as 41, differing from the untrusted source's mention of 15 full-time employees. No additional factual details about the company's products, acquisitions, or financial figures are provided in the user message. The profile is limited to the confirmed facts: location, sector, employee count, IPO date, and website. The company's activities are described as developing and commercializing medical products without further specifics. The source description's product details are disregarded as untrusted, so they are not included in the factual profile. The company's website serves as the primary source for further information. PAVmed Inc is a publicly traded company in the Health Care sector with a presence in New York City. PAVmed is one of the most popular companies on Eulerpool.

Debt Details

Understanding PAVmed's Debt Structure

PAVmed's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing PAVmed's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to PAVmed’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in PAVmed’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about PAVmed stock

Debt of PAVmed is 13.35 M USD in 2025.

Debt of PAVmed changed from 31.86 M USD to 13.35 M USD, representing a -58.10% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt PAVmed since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's PAVmed historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PAVmed

All Key Metrics — PAVmed